A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
Status:
Completed
Trial end date:
2014-09-03
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of cariprazine relative to
placebo in the prevention of relapse of symptoms in participants with schizophrenia.